It was identified among the verified anti-inflammatory components in an extract of Sinomenii caulis and has been proposed to have other potential physiological effects, such as sedative and anxiolytic, reduction of erythrocyte hemolysis, antifungal activity, improvement of LPS-induced acute lung injury, and protection against muscle atrophy. Furthermore, magnoflorine has been identified to be an inhibitor of NF-κB activation and to be an agonist at the β2 -adrenergic receptor.
(S)-Magnoflorine is metabolically derived from (S)-reticuline, a pivotal intermediate in the biosynthesis of numerous BIA structural subgroups, through two enzymatic steps: first, (S)-corytuberine synthase/CYP80G2 to (S)-corytuberine, and secondly, (S)-corytuberine-N-methyltransferase to (S)-magnoflorine.
References
↑El-Kawi, M. A.; Slatkin, D. J.; Schiff, P. L.; Dasgupta, S; Chattopadhyay, S. K.; Ray, A. B. (1984). "Additional alkaloids of Pachygone ovata". J Nat Prod. 47 (3): 459–64. doi:10.1021/np50033a010. PMID6481360.
12de la Peña, June Bryan I.; Lee, Hye Lim; Yoon, Seo Young; Kim, Gun Hee; Lee, Yong Soo; Cheong, Jae Hoon (Oct 2013). "The involvement of magnoflorine in the sedative and anxiolytic effects of Sinomeni Caulis et Rhizoma in mice". J Nat Med. 67 (4): 814–21. doi:10.1007/s11418-013-0754-3. PMID23456265. S2CID14170353.
↑Lee, Heyjin; Tuong, Le Thi; Jeong, Ji Hye; Lee, Sang-Jin; Bae, Gyu-Un; Ryu, Jae-Ha (2017). "Isoquinoline alkaloids from Coptis japonica stimulate the myoblast differentiation via p38 MAP-kinase and Akt signaling pathway". Bioorg Med Chem Lett. 27 (6): 1401–1404. doi:10.1016/j.bmcl.2017.02.003. PMID28228365.
↑Sun, Dan; Han, Yanqi; Wang, Weiya; Wang, Zengyong; Ma, Xiaoyao; Hou, Yuanyuan; Bai, Gang (2016). "Screening and identification of Caulis Sinomenii bioactive ingredients with dual-target NF-κB inhibition and β2-AR agonizing activities". Biomed Chromatogr. 30 (11): 1843–1853. doi:10.1002/bmc.3761. PMID27187693.